Infertility Urological and Genital Diseases Female infertility
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Written consent for this study as well as for the IVF/ICSI treatment are on hand 2. The patient is currently not in psychological treatment 3. The patient has an indication to an IVF/ICSI treatment 4. The patient is in reproductive age (maximal age is 42 years)
Exclusion criteria
Exclusion criteria: 1. Inability to communicate 2. Fundamental contraindications to an IVF/ICSI treatment: 2.1. Acute/chronic infectious diseases: human immunodeficiency virus (HIV), hepatitis B, hepatitis C, syphilis 2.2. Severe psychiatric diseases: schizophrenia, severe depressive disorders 2.3. Acute/chronic addiction 2.4. Carrier of a severe genetic disease 2.5. Age of the female patient is greater than 42 years 3. Need of psychological or psychiatric treatment before or during the study 4. Not any more willing to participate in the study 5. Severe injuries to the protocol 6. Separation of the couple 7. Severe disease of one partner
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Specific stress reactions: 1.1. Infertility distress questionnaire (Fragebogen zur infertilitätsbedingten Belastung [IBS]; 11 items) 1.2. Cognitions in infertility questionnaire (Kognitionen bei Infertilität [KINT]); 20 items) 2. Psychological functioning: 2.1. Centre for Epidemiologic Studies Depression Scale (CES-D); 20 items 2.2. German Inkongruenzfragebogen (K-INK); 23 items 3. Pregnancy rate All primary and secondary outcome measures were assessed at baseline, after 5 weeks, at post-treatment (12 weeks after baseline), and at six-month follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Psychosocial conditions: 1.1. Demographic questionnaire (Socioeconomic Status [SES]; 14 items) 1.2. Relationship Assessment Scale (RAS); 7 items 1.3. Sozialer Support; 7 items 2. Coping, self-efficacy, emotion regulation: 2.1. Coping Inventory for Stressful Situations (CISS) short version; 19 items 2.2. Self-efficacy questionnaire (Selbstwirksamkeit [SWE]; 10 items) 2.3. Emotion Regulation (EMOREG); 26 items All primary and secondary outcome measures were assessed at baseline, after 5 weeks, at post-treatment (12 weeks after baseline), and at six-month follow-up. | — |
Countries
Switzerland